KESSEL MARK

CIK 00012220135 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001222013

Recent Transactions

29 trades

Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2019-09-05+52,000→ 52,000 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2018-07-26+45,500→ 45,550 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2017-08-24+42,500→ 42,500 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2016-08-17+18,500→ 18,500 total
Award
VivoSim Labs, INC.$VIVS
Common Stock
2016-08-17+7,500→ 7,500 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2016-08-17+18,500→ 18,500 total
Award
VivoSim Labs, INC.$VIVS
Common Stock
2016-08-17+7,500→ 15,000 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock, par value $0.001 per share
2012-10-16$4.73/sh−6,000,000→ 3,031,431 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Options (Right to Buy)
2012-05-30+17,500→ 17,500 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Units
2012-03-09+30,000→ 30,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2011-06-01+10,000→ 10,000 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Common Stock, $0.01 par value per share
2011-01-02$0.23/sh+25,000→ 115,000 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Common Stock, $0.01 par value per share
2010-07-01$0.38/sh+25,000→ 27,297,118 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2010-05-12+5,000→ 5,000 total
Other
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock Warrant (Right to Buy)
2010-04-16+9,031,434→ 9,031,434 total
Other
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock Warrant (Right to Buy)
2010-04-16−1,283,200→ 0 total
Other
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock, par value $0.001 per share
2010-04-16+690,631→ 9,031,431 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Common Stock, $0.01 par value per share
2010-01-02$1.14/sh+35,000→ 65,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2009-12-30+20,000→ 20,000 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Common Stock, $0.01 par value per share
2009-12-08$1.14/sh+30,000→ 30,000 total
Other
Oncotelic Therapeutics, Inc.$OTLC
Common Stock, par value $0.01 per share
2009-07-20$1.25/sh+10,000,000→ 27,117,118 total
Award
AGENUS INC$AGEN
Deferred Shares
2006-07-03$2.12/sh+3,065.349→ 81,875.43 total
Award
AGENUS INC$AGEN
Stock Option (right to buy)
2006-06-15$2.02/sh+15,000→ 78,810.081 total
Award
AGENUS INC$AGEN
Deferred Shares
2006-01-13$5.19/sh+1,253.098→ 62,579.885 total
Award
AGENUS INC$AGEN
Deferred Shares
2005-07-14$6.61/sh+982.685→ 60,177.108 total
Award
AGENUS INC$AGEN
Stock Option (right to buy)
2005-06-02$6.60/sh+15,000→ 58,360.371 total
Award
AGENUS INC$AGEN
Deferred Shares
2005-04-08$7.79/sh+834.052→ 44,194.423 total
Award
AGENUS INC$AGEN
Deferred Shares
2005-01-14$8.63/sh+3,360.371→ 43,360.371 total
Award
AGENUS INC$AGEN
Stock Option (right to buy)
2004-05-27$8.41/sh+22,800→ 40,000 total

KESSEL MARK

Recent Transactions

Companies

Recent Filings

Address